One solution we are exploring to help address the global shortage is the utilization of biosimilars in clinical trials, as we are looking into what this would look like with GLP-1s and what potential challenges and solutions may be
33
Retatrutide 20mg Pen is supported by Janoshik third-party testing
Accessing GLP-1 Medications With or Without Insurance GLP-1 medications can be expensive, but programs from manufacturers and TrumpRX can help reduce costs depending on your coverage
For example, A 2023 study in the New England Journal of Medicine found that semaglutide reduced the risk of death from heart disease and nonfatal heart attacks or strokes by about 20 percent for people who were obese or overweight
"There are several reasons someone may not take a GLP-1 consistently, including cost, inconsistent access, manufacturer shortages or loss of coverage," says Gretchen Zimmermann, M.B.A., RD, CDCES, CSOWM